Skip to main content

Table 1 Age, gender and diagnosis group for the 51 subjects

From: Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS)

Group

Gender

Age (years)

 

# Female

# Male

Mean

Range

HC

2

8

45.4

27-52

NIND

11

1

45.5

29-59

SPMS(1)

13

9

53.8

33-69

SPMS (treated) (2)

5

2

53.9

44-60

  1. (1)includes 12 NINDS and 10 lamotrigine placebo subjects.
  2. (2)treated with lamotrigine.
Back to article page

Clinical Proteomics

ISSN: 1559-0275